ANXA2 and neoplasm: DBT has been characterized as a tumor suppressor that inhibits tumor progression and corrects lipid metabolism disorders through the DBT/ANXA2/YAP axis-regulated Hippo signaling pathway in clear cell renal cell carcinoma (Miao et al. 2023).